Gottsegen National Cardiovascular Center

Cardiac Electrophysiology

The Gottsegen National Cardiovascular Center in Budapest focuses on atrial fibrillation research, with particular interest in the management of persistent symptomatic atrial fibrillation and the prevention of recurrent atrial tachyarrhythmia.

  • Atrial fibrillation treatment
  • Cardiac rhythm control
  • Arrhythmia recurrence prevention

Its clinical research activity is centred on interventions that address early disease control in patients with ongoing AF.

Catheter Ablation

The sponsor is actively involved in catheter ablation strategies, with emphasis on pulmonary vein isolation as a first-line approach for patients with symptomatic persistent atrial fibrillation.

  • Pulmonary vein isolation
  • First-line interventional therapy
  • Rhythm intervention

Research activity in this area reflects a strong therapeutic interest in procedural management of atrial arrhythmias.

Cryoballoon-Based Therapy

The centre also studies cryoballoon ablation, including the use of the Arctic Front cryoballoon for isolating pulmonary veins in patients with early-stage AF.

  • Cryoballoon ablation
  • Pulmonary vein triggering
  • Interventional rhythm therapy

This work places focus on device-based treatment options within electrophysiology.

Antiarrhythmic Drug Comparison

Another key area of interest is the comparison between antiarrhythmic drugs and early ablation-based treatment for controlling atrial fibrillation recurrence and maintaining sinus rhythm.

  • Antiarrhythmic medication
  • Rhythm maintenance
  • Atrial arrhythmia control

The sponsor’s clinical work is directed toward treatment choices for patients requiring active rhythm management.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

    Recruiting

    1 1 1 1
    Investigated drugs:
    Bulgaria Denmark Germany Hungary Norway Slovakia +1